Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

FDA Panel Recommends Pulling Preterm Birth Drug From the Market

The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.

Christina Jewett
Author: Christina Jewett

Written by

Christina Jewett

in

Drugs (Pharmaceuticals), Food and Drug Administration, Pregnancy and Childbirth, Premature Babies, Regulation and Deregulation of Industry
←Broadway Theater To Be Renamed In Honor Of Lena Horne
Arnold Schwarzenegger And Sylvester Stallone Carve Pumpkins Together For Halloween→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube